BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28974603)

  • 21. Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies.
    Vianello M; Tavolato B; Armani M; Giometto B
    Cerebellum; 2003; 2(1):77-9. PubMed ID: 12882238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Square-Wave Ocular Oscillation and Ataxia in an Anti-GAD-Positive Individual With Hypothyroidism.
    Brokalaki C; Kararizou E; Dimitrakopoulos A; Evdokimidis I; Anagnostou E
    J Neuroophthalmol; 2015 Dec; 35(4):390-5. PubMed ID: 26035807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment.
    Petrijan T; Menih M
    Cerebellum; 2017 Aug; 16(4):868-871. PubMed ID: 28321713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute Cerebellar Ataxia Associated with Modest Elevation of Anti-GAD Antibodies in a Young Patient.
    Gomez J; Jin D
    Tremor Other Hyperkinet Mov (N Y); 2018; 8():620. PubMed ID: 30647991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute Cerebellar Ataxia Associated with Anti-glutamic Acid Decarboxylase Antibodies Mimicking Miller Fisher Syndrome.
    Nakamura Y; Nakajima H; Hosokawa T; Yamane K; Ishida S; Kimura F
    Intern Med; 2018 Jan; 57(2):269-271. PubMed ID: 29093402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Rare Case of Cerebellar Ataxia Due to Voltage-Gated Calcium Channel and Glutamic Acid Decarboxylase Autoantibodies.
    Annunziata G; Lobo P; Carbuccia C
    Am J Case Rep; 2017 Nov; 18():1251-1255. PubMed ID: 29176543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.
    Hosoi Y; Suzuki-Sakao M; Terada T; Konishi T; Ouchi Y; Miyajima H; Kono S
    J Neurol; 2013 Dec; 260(12):3086-92. PubMed ID: 24091766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebellar ataxia and autoantibodies restricted to glutamic acid decarboxylase 67 (GAD67).
    Guasp M; Solà-Valls N; Martínez-Hernández E; Gil MP; González C; Brieva L; Saiz A; Dalmau J; Graus F; Ariño H
    J Neuroimmunol; 2016 Nov; 300():15-17. PubMed ID: 27806870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A patient with type 1 diabetes mellitus and cerebellar ataxia associated with high titer of circulating anti-glutamic acid decarboxylase antibodies.
    Iwasaki H; Sato R; Shichiri M; Hirata Y
    Endocr J; 2001 Apr; 48(2):261-8. PubMed ID: 11456277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anti-GAD antibodies in paraneoplastic cerebellar ataxia associated with limbic encephalitis and autonomic dysfunction].
    Carra-Dalliere C; Thouvenot E; Bonafé A; Ducray F; Touchon J; Charif M
    Rev Neurol (Paris); 2012 Apr; 168(4):363-6. PubMed ID: 22405456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review.
    Sapana T; Li W; Tian F; Yan W; Dou B; Hua S; Zhuo Z
    Front Immunol; 2023; 14():1274672. PubMed ID: 38077387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Autoantibodies and the Efficacy of Immunotherapy for Autoimmune Cerebellar Ataxia.
    Nanri K; Okuma M; Sato S; Yoneda M; Taguchi T; Mitoma H; Yamada J; Unezaki S; Nagatani T; Otsubo S; Sugawara M; Tanaka N; Mizusawa H
    Intern Med; 2016; 55(5):449-54. PubMed ID: 26935362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.
    Nakajima H; Nakamura Y; Inaba Y; Tsutsumi C; Unoda K; Hosokawa T; Kimura F; Hanafusa T; Date M; Kitaoka H
    J Neuroimmunol; 2018 Apr; 317():84-89. PubMed ID: 29338930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses to and Outcomes of Treatment of Autoimmune Cerebellar Ataxia in Adults.
    Jones AL; Flanagan EP; Pittock SJ; Mandrekar JN; Eggers SD; Ahlskog JE; McKeon A
    JAMA Neurol; 2015 Nov; 72(11):1304-12. PubMed ID: 26414229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
    Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
    Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-glutamic acid decarboxylase (GAD) positive cerebellar Ataxia with transitioning to progressive encephalomyelitis with rigidity and myoclonus (PERM), responsive to immunotherapy: A case report and review of literature.
    Jazebi N; Rodrigo S; Gogia B; Shawagfeh A
    J Neuroimmunol; 2019 Jul; 332():135-137. PubMed ID: 31015081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
    Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
    Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stiff-Person Syndrome Associated with Anti-Glutamic Acid Decarboxylase Autoimmune Encephalitis in a Young Woman: A Case Report.
    Gao SY; Lu J; Zhao CB
    Chin Med Sci J; 2020 Dec; 35(4):387-390. PubMed ID: 33413757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Mediated Cerebellar Ataxia: An Unknown Manifestation of Graft-versus-Host Disease.
    Shargian-Alon L; Raanani P; Rozovski U; Siegal T; Yust-Katz S; Yeshurun M
    Acta Haematol; 2019; 141(1):19-22. PubMed ID: 30439710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].
    Kobayakawa Y; Tateishi T; Kawamura N; Doi H; Ohyagi Y; Kira J
    Rinsho Shinkeigaku; 2010 Feb; 50(2):92-7. PubMed ID: 20196490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.